COVID-19: Vaccines and Therapeutics

President Biden today took a number of actions, including signing a series of executive orders (EOs), aimed at addressing the COVID-19 pandemic.
The Food and Drug Administration updated its guidance and webpage on COVID-19 convalescent plasma.
The American Medical Association announced Current Procedural Terminology codes for reporting the single-dose Janssen (Johnson & Johnson) COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency鈥
The Department of Health and Human Services announced a $20 million investment in several initiatives that will help increase data sharing between health information exchanges and immunization information systems.
President-elect Joe Biden named former Food and Drug Administration commissioner David Kessler, M.D., as Chief Science Officer of COVID Response, a role that will assume the responsibilities of the current head of Operation Warp Speed, the Trump administration effort focused on the development and鈥
President-elect Biden unveiled plans for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems. Biden hopes that Congress will consider the legislation soon after he is inaugurated next week.
President-elect Biden last night unveiled plans for a roughly $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems. Biden hopes that Congress will consider the legislation soon after he is inaugurated next week.
The AHA urged President-elect Biden to provide strong federal leadership on the COVID-19 vaccine distribution and administration process, and it pledged to work with the incoming administration in expediting the administration of vaccines throughout the nation.